ImmunityBio, Inc. (IBRX)
8.70
+0.09
(+1.05%)
USD |
NASDAQ |
Feb 20, 16:00
8.70
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio SG&A Expense (Quarterly) : 36.28M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Novavax, Inc. | 31.66M |
| Krystal Biotech, Inc. | 41.45M |
| Rapt Therapeutics, Inc. | 7.337M |
| Moderna, Inc. | 308.00M |
| Corcept Therapeutics, Inc. | 123.98M |